Security key
45674E208
IN8BIO, INC. - Common Stock, $0.0001 par value per share (INAB)
CUSIP: 45674E208
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 588,817
- Total 13F value
- $1,230,632
- Share change
- +588,817
- SEC-reported price per share
- $2.09
- Number of holders
- 11
- Value change
- +$1,230,632
- Number of buys
- 11
- Shares outstanding
- 9,792,318
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
11
Top holders
10
INAB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
IN8BIO, INC. SEC filings
IN8BIO, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45674E208
Recent filing periods:
Ownership snapshot
Top reported holders of INAB - IN8BIO, INC. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Orin Hirschman
Disclosed value leader
BIOS Capital Management, LP
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G
13F
Lead comparable stake: 4.4%
13D/G row: Orin Hirschman
Showing 1-6 of 15 holder rows.
Quick read
Orin Hirschman leads the comparable SEC ownership view at 4.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Orin Hirschman's linked filing trail.
Comparable ownership
Top 5
Orin Hirschman
4.4%
William Tai-Wei Ho
3.7%
Transcend Partners Opportunity Fu...
2.6%
Alyeska Investment Group, L.P.
2.6%
BIOS Capital Management, LP
88%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Orin Hirschman |
13D/G
|
4.4%
|
$17,987
149,895 shares
|
-$725,036 | 30 Jun 2025 |
| William Tai-Wei Ho |
13D/G
|
3.7%
|
$349,325
151,223 shares
|
$0 | 30 Jun 2025 |
| Transcend Partners Opportunity Fund I LLC |
13D/G
Transcend Partners Opportunity Fund LLC
|
2.6%
|
$248,131
107,416 shares
|
$0 | 30 Jun 2025 |
| Alyeska Investment Group, L.P. |
13F
13D/G
Company
|
2.6%
from 13D/G
|
$345,209
2,079,575 shares
|
— | 31 Mar 2025 |
| BIOS Capital Management, LP |
13F
Company
|
88%
|
$1,427,600
8,600,001 shares
|
— | 31 Mar 2025 |
| FRANKLIN RESOURCES INC |
13F
Company
|
58%
|
$945,570
5,696,202 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
588,817
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q4 2025 Across Filers
Q4 2025 holders
22
Q2 2025 holders
11
Holder diff
-11
| Investor | Q4 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q4 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend